Cargando…
A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.
OBJECTIVE: To compare intravaginal 5-fluorouracil (5-FU) and placebo for the treatment of cervical and/or vaginal human papillomavirus (HPV). METHODS: A randomized, placebo-controlled trial was performed. Women with HPV detected visually or by Papanicolaou (Pap) test and confirmed by colposcopic bio...
Autores principales: | Holmes, M M, Weaver, S H, Vermillion, S T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784744/ https://www.ncbi.nlm.nih.gov/pubmed/10449266 http://dx.doi.org/10.1002/(SICI)1098-0997(1999)7:4<186::AID-IDOG4>3.0.CO;2-Z |
Ejemplares similares
-
Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial
por: Gichuhi, Stephen, et al.
Publicado: (2016) -
Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer
por: Langman, M J S, et al.
Publicado: (1999) -
Pterostilbene on Metabolic Parameters: A Randomized, Double-Blind, and Placebo-Controlled Trial
por: Riche, Daniel M., et al.
Publicado: (2014) -
Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection
por: Dai, Wenkui, et al.
Publicado: (2021) -
The association of cervicovaginal Langerhans cells with clearance of human papillomavirus
por: Dai, Wenkui, et al.
Publicado: (2022)